Common Contracts
3 similar Intercompany Services Agreement contracts by Eidos Therapeutics, Inc.
EX-10.11 14 d544598dex1011.htm EX-10.11 INTERCOMPANY SERVICES AGREEMENTIntercompany Services Agreement • May 5th, 2020 • California
This INTERCOMPANY SERVICES AGREEMENT (this “Agreement”), dated May 1, 2017 and effective as of May 1, 2017 (the “Effective Date”), is made and entered into by and between BridgeBio Services Inc., a Delaware corporation (the “Provider”), and Eidos Therapeutics, Inc., a Delaware corporation (the “Recipient”). The Provider and the Recipient may be referred to collectively herein as the “Parties” and each, a “Party.”
INTERCOMPANY SERVICES AGREEMENTIntercompany Services Agreement • May 25th, 2018 • Eidos Therapeutics, Inc. • Pharmaceutical preparations • California
This INTERCOMPANY SERVICES AGREEMENT (this “Agreement”), dated May 1, 2017 and effective as of May 1, 2017 (the “Effective Date”), is made and entered into by and between BridgeBio Services Inc., a Delaware corporation (the “Provider”), and Eidos Therapeutics, Inc., a Delaware corporation (the “Recipient”). The Provider and the Recipient may be referred to collectively herein as the “Parties” and each, a “Party.”
INTERCOMPANY SERVICES AGREEMENTIntercompany Services Agreement • March 23rd, 2018 • Eidos Therapeutics, Inc. • Pharmaceutical preparations • California
This INTERCOMPANY SERVICES AGREEMENT (this “Agreement”), dated May 1, 2017 and effective as of May 1, 2017 (the “Effective Date”), is made and entered into by and between BridgeBio Services Inc., a Delaware corporation (the “Provider”), and Eidos Therapeutics, Inc., a Delaware corporation (the “Recipient”). The Provider and the Recipient may be referred to collectively herein as the “Parties” and each, a “Party.”
